These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 19427252)

  • 1. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen reduction technology: methods, status of clinical trials, and future prospects.
    Corash L
    Curr Hematol Rep; 2003 Nov; 2(6):495-502. PubMed ID: 14561394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates.
    Corash L
    Vox Sang; 2000; 78 Suppl 2():205-10. PubMed ID: 10938954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates.
    Seghatchian J; Hervig T; Putter JS
    Transfus Apher Sci; 2011 Aug; 45(1):75-84. PubMed ID: 21782517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-transmitted infections.
    Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
    J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen reduction of blood components.
    Solheim BG
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physician's role in selecting a factor replacement therapy.
    Pipe SW
    Haemophilia; 2006 Mar; 12 Suppl 1():21-5; discussion 26-8. PubMed ID: 16445814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of photosensitisers to tropical pathogens in the blood supply.
    Wainwright M; Baptista MS
    Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):240-8. PubMed ID: 21864797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration in hemophilia therapy selection.
    Pipe S
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S23-7. PubMed ID: 16631824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
    Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
    Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted infectious diseases.
    Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
    Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging infectious disease issues in blood safety.
    Chamberland ME; Alter HJ; Busch MP; Nemo G; Ricketts M
    Emerg Infect Dis; 2001; 7(3 Suppl):552-3. PubMed ID: 11485669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward a pathogen-free blood supply.
    McCullough J
    Clin Infect Dis; 2003 Jul; 37(1):88-95. PubMed ID: 12830413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious disease in the blood supply and the public health response.
    Evatt B
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S4-9. PubMed ID: 16631825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-transmitted bacterial infection: risks, sources and interventions.
    Wagner SJ
    Vox Sang; 2004 Apr; 86(3):157-63. PubMed ID: 15078249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative strategies in assuring blood safety: An overview.
    Epstein JS
    Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.